Citations

Showing 10 of 108036 citations.

Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors
Shah, Paras , Moreira, Daniel M. , Okhunov, Zhamshid , Patel, Vinay , Chopra, Sameer , Razmaria, Aria, Alom, Manaf, George, Arvin K. , Yaskiv, Oksana, Schwartz, Michael J. , Desai, Mihir , Vira, Manish , Richstone, Lee, Landman, Jaime, Shalhav, Arieh L., Gill, Inderbir S. , Kavoussi, Louis R., Gill, Inderbir S

Mayo Clinic

Journal of Urology | February 20, 2016 | Volume: 196 | Issue: 2 | Pages: 327-334

10.1016/j.juro.2016.02.075 | PMID 26907508 Get It

Long‐term Outcomes After Osteochondral Autograft Transfer: A Systematic Review at Mean Follow‐up of 10.2 Years
Pareek, Ayoosh , Reardon, Patrick J., Levy, Bruce A. , Krych, Aaron J. , Maak, Travis G. , Stuart, Michael J. , Krych, Aaron J

Mayo Clinic

Arthroscopy | February 20, 2016 | Volume: 32 | Issue: 6 | Pages: 1174-1184

10.1016/j.arthro.2015.11.037 | PMID 26906461 Get It

Purpose To evaluate (1) activity level and knee function, (2) reoperation and failure rates, and (3) risk factors for reoperation and failure of osteochondral autograft transfer (OAT) at minimum long‐term follow‐up. Methods A comprehensive review was performed for long‐term outcomes after OAT. Studies reported on activity‐based outcomes (Tegner Activity Scale) and clinical outcomes (Lysholm score and International Knee Documentation Committee score). Reoperation and failure rates, as defined by the publishing authors, were recorded for each study. Modified Coleman Methodology Scores were calculated to assess study methodological quality. Results Ten studies with a total of 610 patients with an average age of 27.0 years at the time of surgery and a mean follow‐up of 10.2 years were included. The mean defect size was 2.6 cm 2 (range, 0.9 to 20.0 cm 2 ). The mean duration of symptoms before surgery was 4.8 years. From preoperative to final follow‐up, International Knee Documentation Committee scores and Lysholm scores improved significantly by 42.4 (95% confidence interval [CI], 31.8 to 53.1, P < .001) and 21.1 (95% CI, 12.2 to 30.0, P < .01), respectively. Tegner score did not improve significantly (0.76, 95% CI, −0.83 to 2.36, P = .35). Overall failure rate was 28% and reoperation rate was 19%. Increased age, previous surgery, and defect size positively correlated with increased risk of failure. Concomitant surgical procedures negatively correlated with failure rate. Conclusions Overall, OAT showed successful outcomes in 72% of patients at long‐term follow‐up. Increased age, previous surgery, and defect size correlated positively with failure rate, whereas success improved with concomitant surgical procedures. Nonetheless, this systematic review is limited by heterogeneity in a surgical technique, lesion and patient characteristics, and reporting of nonstandardized outcome measures. Level of Evidence Level IV, systematic review of Level I‐IV studies.
Antibiotics and onset of functional gastrointestinal disorders
Grover, Madhusudan , Talley, Nicholas J.

Mayo Clinic

Neurogastroenterology & Motility | February 20, 2016 | Volume: 28 | Issue: 3 | Pages: 451-451

10.1111/nmo.12781 | PMID 26891063 Get It

Big Data Transforms Discovery–Utilization Therapeutics Continuum
Waldman, Scott A. , Terzic, André , Waldman, Scott A

Mayo Clinic

Clinical Pharmacology & Therapeutics | February 20, 2016 | Volume: 99 | Issue: 3 | Pages: 250-254

10.1002/cpt.322 | PMID 26888297 Get It

Enabling omic technologies adopt a holistic view to produce unprecedented insights into the molecular underpinnings of health and disease, in part, by generating massive high‐dimensional biological data. Leveraging these systems‐level insights as an engine driving the healthcare evolution is maximized through integration with medical, demographic, and environmental datasets from individuals to populations. Big data analytics has accordingly emerged to add value to the technical aspects of storage, transfer, and analysis required for merging vast arrays of omic‐, clinical‐, and eco‐datasets. In turn, this new field at the interface of biology, medicine, and information science is systematically transforming modern therapeutics across discovery, development, regulation, and utilization.
Frailty Trajectories in an Elderly Population‐Based Cohort
Chamberlain, Alanna M. , Manemann, Sheila M., Yawn, Barbara P. , Jacobson, Debra J., Fan, Chun , Grossardt, Brandon R. , Roger, Véronique L. , Sauver, Jennifer L. St. , Finney Rutten, Lila J, St Sauver, Jennifer L, Rutten, Lila J. Finney , St Sauver, Jennifer L , Chamberlain, Alanna M , Grossardt, Brandon R

Mayo Clinic

Journal of the American Geriatrics Society | February 20, 2016 | Volume: 64 | Issue: 2 | Pages: 285-292

10.1111/jgs.13944 | PMID 26889838 Get It

Objectives To identify distinct frailty trajectories (clusters of individuals following a similar progression of frailty over time) in an aging population and to estimate associations between frailty trajectories and emergency department visits, hospitalizations, and all‐cause mortality. Design Population‐based cohort study. Setting Olmsted County, Minnesota. Participants Olmsted County, Minnesota residents aged 60–89 in 2005. Measurements Longitudinal changes in frailty between 2005 and 2012 were measured by constructing a yearly Rockwood frailty index incorporating body mass index, 17 comorbidities, and 14 activities of daily living. The frailty index measures variation in health status as the proportion of deficits present of the 32 considered (range 0–1). Results Of the 16,443 Olmsted County residents aged 60–89 in 2005, 12,270 (74.6%) had at least 3 years of frailty index measures and were retained for analysis. The median baseline frailty index increased with age (0.11 for 60–69, 0.14 for 70–79, 0.19 for 80–89). Three distinct frailty trajectories were identified in individuals aged 60–69 at baseline and two trajectories in those aged 70–79 and 80–89. Within each decade of age, increasing frailty trajectories were associated with greater risks of emergency department visits, hospitalization, and all‐cause mortality, even after adjustment for baseline frailty index. Conclusion The number of frailty trajectories differed according to age. Within each age group, those in the highest frailty trajectory had greater healthcare use and worse survival. Frailty trajectories may offer a way to target aging individuals at high risk of hospitalization or death for therapeutic or preventive interventions.
Further Defining the Role of the Laboratory Genetic Counselor
Waltman, Lindsey, Runke, Cassandra , Balcom, Jessica R. , Riley, Jacquelyn D. , Lilley, Margaret , Christian, Susan , Zetzsche, Lindsay H., Goodenberger, McKinsey L. , Balcom, Jessica, Zetzsche, Lindsay, Goodenberger, McKinsey

Mayo Clinic

Journal of Genetic Counseling | February 20, 2016 | Volume: 25 | Issue: 4 | Pages: 786-798

10.1007/s10897-015-9927-4 | PMID 26895873 Get It

AbstractLaboratory genetic counseling is becoming increasingly common as a result of increased laboratory services and genetic testing menus, as well as growing job responsibilities. Christian et al. (2012) provided the first quantitative data regarding the roles of the laboratory‐based genetic counselor (LBGC) finding that two of the most prevalent roles are as customer liaisons and communicators of test results. The goal of the present study was to further delineate the role of the LBGC by addressing specific tasks that LBGCs are involved with on a day‐to‐day basis. A survey was designed to expand upon themes identified in the Christian et al. (2012) study by querying specific tasks performed in several categories of potential LBGC job duties. An invitation for LBGCs to participate was distributed via email to the membership of the National Society of Genetic Counselors (NSGC) and the Canadian Association of Genetic Counsellors (CAGC). We identified 121 genetic counselors who primarily work in the laboratory setting or whose job role includes a laboratory component. Almost all respondents performed customer liaison/case coordination (95 %), and interpretation and result reporting (88 %). The most frequently performed tasks within these categories involved addressing questions from clients, making phone calls with genetic testing results, obtaining clinical or family history information for results interpretation, and composing case‐specific interpretations for unique results and/or obtaining literature references to support interpretations. The study results also point to trends of expanding roles in sales and marketing, variant interpretation and management responsibilities. Results of this study may be useful to further define the full scope of practice of LBGCs, aid in the development of new LBGC positions and expand current positions to include roles related to test development, research, and student supervision. It may also aid in curriculum updates for training programs to increase exposure to LBGC roles.
Surgical Therapies and Tissue Engineering: At the Intersection Between Innovation and Regulation
Rubin, J. Peter, Gurtner, Geoffrey C. , March, Keith L. , Seppänen‐Kaijansinkko, Riitta , Yaszemski, Michael J. , Yoo, James J. , Liu, Wei Xin

Mayo Clinic

Tissue Engineering Part A | February 19, 2016 | Volume: 22 | Issue: 5-6 | Pages: 397-400

10.1089/ten.tea.2016.0002 | PMID 26895615 Get It

Long-term clinical outcomes following 3- and 4-level anterior cervical discectomy and fusion
Ramos, Rafael De la Garza , Ramhmdani, Seba , Kosztowski, Thomas, Bydon, Mohamad , Sciubba, Daniel M. , Wolinsky, Jean‐Paul , Witham, Timothy F. , Gokaslan, Ziya L. , Bydon, Ali , Xu, Risheng , De la Garza Ramos, Rafael

Mayo Clinic

Journal of Neurosurgery: Spine | February 19, 2016 | Volume: 24 | Issue: 6 | Pages: 885-891

10.3171/2015.10.spine15795 | PMID 26895527 Get It

OBJECTIVE The purpose of this study was to report the long-term clinical outcomes following 3- and 4-level anterior cervical discectomy and fusion (ACDF). METHODS A retrospective review of all adult neurosurgical patients undergoing elective ACDF for degenerative disease at a single institution between 1996 and 2013 was performed. Patients who underwent first-time 3- or 4-level ACDF were included; patients with previous cervical spine surgery, those undergoing anterior/posterior approaches, and those with corpectomy were excluded. Outcome measures included perioperative complication rates, fusion rates, need for revision surgery, Nurick Scores, Odom's criteria, symptom resolution, neck visual analog scale (VAS) pain score, and persistent narcotics usage. RESULTS Seventy-one patients who underwent 3-level ACDF and 26 patients who underwent 4-level ACDF were identified and followed for an average of 7.6 ± 4.2 years. There was 1 case (3.9%) of deep wound infection in the 4-level group and 1 case in the 3-level group (1.4%; p = 0.454). Postoperatively, 31% of patients in the 4-level group complained of dysphagia, compared with 12.7% in the 3-level group (p = 0.038). The fusion rate was 84.6% after 4-level ACDF and 94.4% after 3-level ACDF (p = 0.122). At last follow-up, a significantly higher proportion of patients in the 4-level group continued to have axial neck pain (53.8%) than in the 3-level group (31%; p = 0.039); the daily oral morphine equivalent dose was significantly higher in the 4-level group (143 ± 97 mg/day) than in the 3-level group (25 ± 10 mg/day; p = 0.030). Outcomes based on Odom's criteria were also different between cohorts (p = 0.044), with a significantly lower proportion of patients in the 4-level ACDF group experiencing an excellent/good outcome. CONCLUSIONS In this study, patients who underwent 4-level ACDF had significantly higher rates of dysphagia, postoperative neck pain, and postoperative narcotic usage when compared with patients who underwent 3-level ACDF. Pseudarthrosis and deep wound infection rates were also higher in the 4-level group, although this did not reach statistical significance. Additionally, a smaller proportion of patients achieved a good/excellent outcome in the 4-level group than in the 3-level group. These findings suggest a significant increase of perioperative morbidity and worsened outcomes for patients who undergo 4- versus 3-level ACDF.
Assessment of low-dose i.v. ketamine infusions for adjunctive analgesia
Kator, Sarah , Correll, Darin , Levinson, Radmila, Noronha, Genevieve N., Adams, Christopher , Ou, Judy Y.

Mayo Clinic

American Journal of Health-System Pharmacy | February 19, 2016 | Volume: 73 | Issue: 5_Supplement_1 | Pages: S22-S29

10.2146/ajhp150367 | PMID 26896522 Get It

Impact of Electronic-Alerting of Acute Kidney Injury: Workgroup Statements from the 15 th ADQI Consensus Conference
Hoste, Eric A. J. , Wilson, F. Perry , Ronco, Claudio , Goldstein, Stuart L. , Bagshaw, Sean M. , Group, on behalf of the 15 ADQI Consensus, Kashani, Kianoush , Gibney, R. T. Noel , Kellum, John A. , Group, on behalf of the 15 ADQI Consensus, Wilson, F Perry , Ronco, Claudio , Bagshaw, Sean M

Mayo Clinic

Canadian Journal of Kidney Health and Disease | February 19, 2016 | Volume: 3 | Issue: No issue available | Pages: No page available

10.1186/s40697-016-0101-1 | PMID 26925246 Get It

Purpose of the review: Among hospitalized patients, acute kidney injury is common and associated with significant morbidity and risk for mortality. The use of electronic health records (EHR) for prediction and detection of this important clinical syndrome has grown in the past decade. The steering committee of the 15 th Acute Dialysis Quality Initiative (ADQI) conference dedicated a workgroup with the task of identifying elements that may impact the course of events following Acute Kidney Injury (AKI) e-alert. Sources of information: Following an extensive, non-systematic literature search, we used a modified Delphi process to reach consensus regarding several aspects of the utilization of AKI e-alerts. Findings: Topics discussed in this workgroup included progress in evidence base practices, the characteristics of an optimal e-alert, the measures of efficacy and effectiveness, and finally what responses would be considered best practices following AKI e-alerts. Authors concluded that the current evidence for e-alert system efficacy, although growing, remains insufficient. Technology and human-related factors were found to be crucial elements of any future investigation or implementation of such tools. The group also concluded that implementation of such systems should not be done without a vigorous plan to evaluate the efficacy and effectiveness of e-alerts. Efficacy and effectiveness of e-alerts should be measured by context-specific process and patient outcomes. Finally, the group made several suggestions regarding the clinical decision support that should be considered following successful e-alert implementation. Limitations: This paper reflects the findings of a non-systematic review and expert opinion. Implications: We recommend implementation of the findings of this workgroup report for use of AKI e-alerts.